Volume 23 Supplement 1
The publication of this supplement was supported by Merck KGaA, Darmstadt, Germany. Merck KGaA had no involvement in the preparation, review, or approval of the content. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editors declare that they have no competing interests.
Naples, Italy27-28 May 2022
Editors:
Carlo Alviggi | University of Naples Federico II
Robert Fischer | AMEDES Group
Pasquale de Franciscis | University of Campania Luigi Vanvitelli
Raoul Orvieto | Chaim Sheba Medical Center
The process of follicle development is closely regulated by two pituitary gonadotropins: follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Traditionally, folliculogenesis is considered to be div...
Ovarian stimulation (OS) is a crucial component of clinical IVF treatment that strongly influences outcomes. As such, it is useful to understand the indicators for successful OS during IVF. As OS leads to mult...
It is widely recognized that luteinizing hormone (LH) activity is pivotal during folliculogenesis. Nonetheless, the use of LH during ovarian stimulation remains a matter of debate. Indeed, women with good LH f...
Luteinizing hormone (LH) is fundamental to support development and reproduction. It acts through a receptor expressed in the gonads, modulating mitogenic, anti-apoptotic, and steroidogenic signals. LH is also ...
The production of spermatozoa, a process known as spermatogenesis, is primarily controlled by follicle-stimulating hormone (FSH) and luteinizing hormone (LH)-driven testosterone. LH acts on the Leydig cells, s...
As part of a conventional controlled ovarian hyperstimulation (COH) regimen, final follicular maturation is usually triggered by a single bolus dose of human chorionic gonadotropin (hCG). COH, which combines G...
The Correction to this article has been published in Reproductive Biology and Endocrinology 2025 23:26
IVF treatments should be personalized to collect an appropriate number of oocytes, taking into account the woman’s age and ovarian reserve, in order to maximize the efficacy and efficiency of the IVF process. ...
Citation Impact 2023
Journal Impact Factor: 4.2
5-year Journal Impact Factor: 5.3
Source Normalized Impact per Paper (SNIP): 1.306
SCImago Journal Rank (SJR): 1.208
Speed 2024
Submission to first editorial decision (median days): 5
Submission to acceptance (median days): 102
Usage 2024
Downloads: 1,912,122
Altmetric mentions: 867
We are delighted to announce our 2023 CiteScore of 7.9! Reproductive Biology and Endocrinology remains firmly in Q1 within the Obstetrics & Gynecology and Reproductive Medicine categories.